IRIS

The study evaluated the efficacy of beclomethasone dipropionate/formoterol fumarate (BDP/FF) extrafine combination versus fluticasone propionate/salmeterol (FP/S) combination in COPD patients.

Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPD / Singh, Dave; Nicolini, Gabriele; Bindi, Eddi; Corradi, Massimo; Guastalla, Daniele; Kampschulte, Jorg; Pierzchała, Władysław; Sayiner, Abdullah; Szilasi, Mária; Terzano, Claudio; Vestbo, Jørgen. - In: BMC PULMONARY MEDICINE. - ISSN 1471-2466. - 14:1(2014), pp. 2-9. [10.1186/1471-2466-14-43]

Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPD

CORRADI, Massimo;
2014-01-01

Abstract

The study evaluated the efficacy of beclomethasone dipropionate/formoterol fumarate (BDP/FF) extrafine combination versus fluticasone propionate/salmeterol (FP/S) combination in COPD patients.
2014
Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPD / Singh, Dave; Nicolini, Gabriele; Bindi, Eddi; Corradi, Massimo; Guastalla, Daniele; Kampschulte, Jorg; Pierzchała, Władysław; Sayiner, Abdullah; Szilasi, Mária; Terzano, Claudio; Vestbo, Jørgen. - In: BMC PULMONARY MEDICINE. - ISSN 1471-2466. - 14:1(2014), pp. 2-9. [10.1186/1471-2466-14-43]
1.1 Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2784259
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 26
social impact